The life sciences industry is poised for better times in 2026, according to speakers at the McDermott Forum, held on January 13, 2026, during the 44th annual J.P. Morgan Healthcare Conference. Hosted by McDermott Will & Schulte with knowledge partner Ernst & Young (EY) at the Ritz-Carlton San Francisco, the event featured insights from senior life sciences, investment, and policy leaders on a broad range of subjects, including merger and acquisition activity, trade policy, drug pricing, investment trends, and global health. Speakers pointed to renewed engagement from strategic buyers, private equity sponsors, and public market investors alike. Here, McDermott and EY share key takeaways from the event.
Read the full article: JPM Briefing: Life Sciences Investors Cautiously Optimistic for 2026 and Beyond //
Source: https://www.lexology.com/library/detail.aspx?g=71aed1be-5425-46b9-b411-113e747f4d0f